ASX 200 News: DTR, CDR Among Key Movers on Resources and Gold Updates

May 05, 2025 05:03 PM AEST | By Team Kalkine Media
 ASX 200 News: DTR, CDR Among Key Movers on Resources and Gold Updates

Highlights:

  • Dateline Resources advances Colosseum rare earths-gold project with US listing plans

  • Codrus Minerals prepares extensive drilling at Bull Run gold site in Oregon

  • ASX 200 gains attention as small caps in mining and biotech sectors show movement

Dateline Resources (ASX:DTR) and Codrus Minerals (ASX:CDR) are among the stocks drawing attention in the mining and resource space, contributing to recent moves in small cap activity across the broader asx 200 landscape. This follows ongoing updates from both domestic and international resource projects, while movements in major indexes such as the All Ordinaries and the ASX Small Ordinaries reflect broader market momentum.

Dateline Resources operates in the mining sector with focus areas in both gold and rare earth elements. The company has announced intentions to expand accessibility to its shares via a planned listing on the US OTCQB exchange. This step follows existing trading on another over-the-counter platform. Dateline confirmed it will retain its primary listing on the ASX.

The company’s Colosseum project in California is under fresh spotlight after references to the site emerged through official communications from the United States. Authorities have confirmed regulatory progress on the mine, which holds rare earth elements and gold. Dateline has indicated that development activities are progressing, including work toward a feasibility study. The Colosseum site includes an existing gold resource and is now part of broader strategic narratives related to supply chain diversification.

Codrus Minerals Secures Permit for Bull Run Drilling Program

Codrus Minerals is active in gold exploration and is advancing its Bull Run project in Oregon, United States. The company announced receipt of a drilling permit, paving the way for extensive work across multiple sites within the historic gold-producing area. Previous exploration at Bull Run has returned high-grade results, and Codrus plans to resume drilling operations aimed at defining further mineralisation.

The Bull Run region includes the old Record Mine, a site that produced gold historically and has recently attracted exploration focus due to notable intercepts. With the permit in place, Codrus plans to mobilise and commence drilling across designated areas. The site is located within a district that has seen limited modern exploration.

Other Small Caps Show Momentum in Broader Trading

In the broader small cap landscape, other mining and biotech stocks recorded gains on the ASX. Boab Metals (ASX:BML), Empire Resources (ASX:ERL), Triton Minerals (ASX:TON), and Renegade Exploration (ASX:RNX) were among the mining-related tickers trading higher. Companies such as Avecho Biotech (ASX:AVE), Chimeric Therapeutics (ASX:CHM), and Memphasys (ASX:MEM) were also active in the biotech space.

Movement in these names contributed to activity outside of the larger indices but aligns with ongoing market themes including metals exploration, regulatory shifts, and development updates. Additional mentions included Codrus’s further involvement in Oregon and Dateline’s integration of rare earths into its asset mix.

Market Context and Broader Sector Indicators

Price movements in gold, lithium carbonate, nickel, and copper reflect dynamic shifts across commodities. Fluctuations in the Chinese market and temporary closures have also contributed to changes in demand patterns. Commodity sector participants continue to respond to international developments including export policy, geopolitical tensions, and sector-specific updates related to energy and critical materials.

As activity unfolds across different asset classes and sectors, the ASX maintains focus on mining and exploration developments. The presence of multiple mining juniors in daily top gainers lists highlights ongoing attention in the sector, with broader participation also visible across biotech and wellness categories.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.